tirzepatide ocd Obsessive-Compulsive Disorder (OCD) TMS Inst. Scottsdale AZ Novel Treatment Options for OCD
Description
Color-coded to gauge
Recent studies suggest that tirzepatide, a dual glucose-dependent insulinotropic-peptide (GIP) and glucagon-like peptide-1 receptor agonist (GLP-1 RA), has significant weight loss effects
A daily loop that guards it a nutrition floor, a dose-week rhythm, and gentle meals for the hard days
Enjoy less hunger and more control, delivered in a refreshing blood orange, lemon, lime drink with only 20 calories!*
Methods Retrospective study utilizing data from a federated research network (TriNetX)
